PMX

Recent Finacing

Series A

Recent Raise

Undisclosed

PMX develops AI diagnostic tools and a multi-modality CT/MRI imaging platform quantifying organs and biomarkers for earlier Alzheimer’s and Parkinson’s detection, operating from Seoul with a Chicago FDA-research office.